Fount raises US$12m ahead of launching new women’s health products

The human performance company Fount has secured US$12m in funding as it prepares to launch new sleep and women’s health products.

Fount began its work with professional athletes and Navy SEALs and now offers customised health and performance optimisation programmes through its flagship offering, Fount Pro.

According to developers, the programmes combine n=1 experimentation with one-on-one coaching and enable clients to optimise their energy, focus, mood, sleep, gut health, longevity, fertility, and body composition.

The company uses data sets and AI expertise to create new products, such as FlyKitt, a system meant to prevent jet lag by reducing inflammation and shifting your circadian rhythms.

“At Fount, we’ve taken our expertise in optimising outcomes for the highest performers in the toughest environments on Earth and built tools that can help anyone achieve their health and performance goals,” said Andrew Herr, founder and CEO of Fount.

“With this funding, we are expanding our world-class Fount Pro service and preparing to launch new products to solve high-impact challenges.

“The effectiveness of our products and services shows the value of merging the data from our experiment-driven approach with the latest AI technology.

“We will continue to leverage these advantages to make world-class tools available beyond pro sports and special operations.”

The funding round, led by Amity Ventures with participation from Los Angeles Dodgers-associated Elysian Park Ventures, Not Boring Capital, Allen & Co and Champion Hill Ventures, will help Fount launch a series of new products for sleep and women’s health, with results showing effects such as a 90 per cent reduction in symptoms of premenstrual syndrome.

CJ Reim, managing partner of Amity Ventures, said: “Many companies, protocols, or products offer point solutions delivering the latest diet, sensor, meditation practice, or fitness routine.

“Fount sits on top of all of these point solutions delivering a personalised, experiment-driven approach to implementing the health and performance interventions that work for you.

“We invested in Fount because they are the only company to bring together the health insights, data and AI expertise required to scale this to millions of people.”